Articlenpj antimicrobials and resistance2026
Exploiting DprE2 pathway redundancy to enhance potency and overcome resistance to pretomanid in Mycobacterium tuberculosis.
Kamel Djaout et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.